Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Structure-Based Design and Biological Evaluation of Novel Caspase-2 Inhibitors Based on the Peptide

Journal Article · · ACS Pharmacol. Transl. Sci.

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
DOE - Office Of Science; National Institutes of Health (NIH)
OSTI ID:
1844617
Journal Information:
ACS Pharmacol. Transl. Sci., Vol. 5, Issue (1)
Country of Publication:
United States
Language:
ENGLISH

References (49)

Probing the Biology of Alzheimer's Disease in Mice journal June 2010
Role of Tau Protein in Both Physiological and Pathological Conditions journal April 2004
Post-translational modifications of tau protein in Alzheimer’s disease journal October 2004
Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration journal December 2010
Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies journal January 2016
Pathological Tau Disrupts Ongoing Network Activity journal March 2015
Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function journal July 2005
Caspase-2 cleavage of tau reversibly impairs memory journal October 2016
Caspases: Therapeutic Targets in Neurologic Disease journal October 2014
A soluble tau fragment generated by caspase-2 is associated with dementia in Lewy body disease journal July 2019
ER Stress Drives Lipogenesis and Steatohepatitis via Caspase-2 Activation of S1P journal September 2018
Mechanisms and disease consequences of nonalcoholic fatty liver disease journal May 2021
Caspase-2 and tau—a toxic partnership? journal November 2016
Caspases and Kinases in a Death Grip journal September 2009
The protein structures that shape caspase activity, specificity, activation and inhibition journal November 2004
Proteolytic Cleavage of Polymeric Tau Protein by Caspase-3: Implications for Alzheimer Disease journal December 2013
Caspase-Cleaved Tau Impairs Mitochondrial Dynamics in Alzheimer’s Disease journal January 2017
Mechanisms of Caspase Activation and Inhibition during Apoptosis journal March 2002
Structural and Enzymatic Insights into Caspase-2 Protein Substrate Recognition and Catalysis journal August 2011
Caspase Substrates and Inhibitors journal June 2013
Structural and Functional Analysis of Caspase Active Sites journal March 2003
Exploiting differences in caspase-2 and -3 S2 subsites for selectivity: Structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors journal October 2011
Potent and selective caspase-2 inhibitor prevents MDM-2 cleavage in reversine-treated colon cancer cells journal April 2019
Crystal Structure of Caspase-2, Apical Initiator of the Intrinsic Apoptotic Pathway journal October 2003
Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways journal November 2007
Neuroprotective effects of M826, a reversible caspase-3 inhibitor, in the rat malonate model of Huntington's disease: Neuroprotection by reversible caspase-3 inhibition journal February 2004
Caspases and their substrates journal May 2017
Structural and Kinetic Analysis of Caspase-3 Reveals Role for S5 Binding Site in Substrate Recognition journal July 2006
Docking Covalent Inhibitors: A Parameter Free Approach To Pose Prediction and Scoring journal June 2014
Structure-Based Virtual Screening Approach for Discovery of Covalently Bound Ligands journal June 2014
Automated synthesis of peptide C-terminal aldehydes journal April 1992
Automatic procedures for the synthesis of difficult peptides using oxyma as activating reagent: A comparative study on the use of bases and on different deprotection and agitation conditions journal April 2018
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules journal March 2017
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays journal April 2010
The Ecstasy and Agony of Assay Interference Compounds journal February 2017
Insight into the mechanism of action and selectivity of caspase-3 reversible inhibitors through in silico studies journal November 2017
Quantum Mechanics/Molecular Mechanics Study on Caspase-2 Recognition by Peptide Inhibitors journal September 2020
Discovery of covalent enzyme inhibitors using virtual docking of covalent fragments journal January 2019
Targeting neonatal ischemic brain injury with a pentapeptide-based irreversible caspase inhibitor journal September 2011
Identification of Potent and Selective Small-Molecule Inhibitors of Caspase-3 through the Use of Extended Tethering and Structure-Based Drug Design journal October 2002
A Highly Potent and Selective Caspase 1 Inhibitor that Utilizes a Key 3-Cyanopropanoic Acid Moiety journal March 2010
Production of Circularly Permuted Caspase-2 for Affinity Fusion-Tag Removal: Cloning, Expression in Escherichia coli, Purification, and Characterization journal November 2020
Expression, Purification, and Characterization of Caspases journal February 2002
Allosteric modulation of caspase 3 through mutagenesis journal June 2012
Caspase-3 binds diverse P4 residues in peptides as revealed by crystallography and structural modeling journal May 2009
Data processing and analysis with the autoPROC toolbox journal March 2011
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
Features and development of Coot journal March 2010
Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction journal December 1973